Key result
ARBs suppress mesenteric TRPC expression and norepinephrine-induced vasomotion in hypertensive rats, unlike amlodipine.
Answers are grounded in this paper and cite their sources.
Vasomotion describes oscillations of arterial vascular tone due to synchronized changes of intracellular calcium concentrations. Since increased calcium influx into vascular smooth muscle cells from spontaneously hypertensive rats (SHR) has been associated with variances of transient receptor potential canonical (TRPC) channels, in the present study we tested the hypothesis that increased vasomotion in hypertension is directly linked to increased TRPC expression. Using a small vessel myograph we observed significantly increased norepinephrine-induced vasomotion in mesenteric arterioles from SHR compared to normotensive Wistar-Kyoto (WKY) rats. Using immunoblottings we obtained significantly increased expression of TRPC1, TRPC3 and TRPC5 in mesenteric arterioles from SHR compared to WKY, whereas TRPC4 and TRPC6 showed no differences. Norepinephrine-induced vasomotion from SHR was significantly reduced in the presence of verapamil, SKF96365, 2-aminoethoxydiphenylborane (2-APB) or gadolinium. Pre-incubation of mesenteric arterioles with anti-TRPC1 and anti-TRPC3 antibodies significantly reduced norepinephrine-induced vasomotion and calcium influx. Control experiments with pre-incubation of TRPC antibodies plus their respective antigenic peptide or in the presence of anti-β-actin antibodies or random immunoglobulins not related to TRPC channels showed no inhibitory effects of norepinephrine-induced vasomotion and calcium influx. Administration of candesartan or telmisartan, but not amlodipine to SHR for 16 weeks significantly reduced either the expression of TRPC1, TRPC3 and TRPC5 as well as norepinephrine-induced vasomotion in mesenteric arterioles. In conclusion we gave experimental evidence that the increased TRPC1, TRPC3 and TRPC5 expression in mesenteric arterioles from SHR causes increased vasomotion in hypertension.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2009) studied Hypertension (spontaneously hypertensive rats). Candesartan or telmisartan (and ex vivo TRPC channel inhibition) vs. Amlodipine or normotensive Wistar-Kyoto (WKY) control was evaluated on Norepinephrine-induced vasomotion and TRPC1, TRPC3, and TRPC5 protein expression in mesenteric arterioles. Candesartan or telmisartan for 16 weeks (unlike amlodipine) significantly reduced TRPC1, TRPC3, and TRPC5 expression and norepinephrine-induced vasomotion in hypertensive rat mesenteric arterioles.
Synapse has enriched 10 related papers. Consider them for comparative context: